肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2021 BSH指南：成人骨髓增生异常综合征的管理

2021-06-27 英国血液病学学会 Br J Haematol

成人骨髓增生异常综合征

2021年6月，英国血液病学学会(BSH)发布了成人骨髓增生异常综合征的管理指南，本文是对2014年之内的更新，主要内容涉及成人骨髓增生异常综合征的治疗。

中文标题：

2021 BSH指南：成人骨髓增生异常综合征的管理

英文标题：

Guidelines for the management of adult myelodysplastic syndromes

发布机构：

英国血液病学学会

发布日期：

2021-06-27

简要介绍：

2021年6月，英国血液病学学会(BSH)发布了成人骨髓增生异常综合征的管理指南，本文是对2014年之内的更新，主要内容涉及成人骨髓增生异常综合征的治疗。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 BSH指南：成人骨髓增生异常综合征的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=2e3051c002211990, title=2021 BSH指南：成人骨髓增生异常综合征的管理, enTitle=Guidelines for the management of adult myelodysplastic syndromes, guiderFrom=Br J Haematol, authorId=0, author=, summary=2021年6月，英国血液病学学会(BSH)发布了成人骨髓增生异常综合征的管理指南，本文是对2014年之内的更新，主要内容涉及成人骨髓增生异常综合征的治疗。, cover=https://img.medsci.cn/20211017/1634479229124_1608702.jpg, journalId=0, articlesId=null, associationId=1339, associationName=英国血液病学学会, associationIntro=, copyright=0, guiderPublishedTime=Sun Jun 27 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年6月，英国血液病学学会(BSH)发布了成人骨髓增生异常综合征的管理指南，本文是对2014年之内的更新，主要内容涉及成人骨髓增生异常综合征的治疗。</span></p>, tagList=[TagDto(tagId=116113, tagName=成人骨髓增生异常综合征)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2580, guiderKeyword=骨髓增生异常综合征, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3929, appHits=115, showAppHits=0, pcHits=1197, showPcHits=3808, likes=0, shares=4, comments=7, approvalStatus=1, publishedTime=Sun Oct 17 23:05:42 CST 2021, publishedTimeString=2021-06-27, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Sun Oct 17 22:38:16 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Wed Jan 03 19:46:07 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 BSH指南：成人骨髓增生异常综合征的管理.pdf)])
2021 BSH指南：成人骨髓增生异常综合征的管理.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1083850, encodeId=8b0a1083850f4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d9a5236987, createdName=10188348, createdTime=Fri Dec 24 11:04:24 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083845, encodeId=769e108384550, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c82c5636469, createdName=ms2000001848287989, createdTime=Fri Dec 24 10:58:07 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083708, encodeId=e8571083e0835, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/30d83b9eb58247d9a772088edfb77f9e/ca51b8367de94851a2275db463695568.jpg, createdBy=3d162090300, createdName=齐广西, createdTime=Thu Dec 23 22:56:18 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064547, encodeId=52e2106454eb8, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Oct 28 07:01:39 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061364, encodeId=50af106136404, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1e05489924, createdName=ms1000002136354097, createdTime=Mon Oct 18 06:43:36 CST 2021, time=2021-10-18, status=1, ipAttribution=)]
    2021-12-24 10188348

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1083850, encodeId=8b0a1083850f4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d9a5236987, createdName=10188348, createdTime=Fri Dec 24 11:04:24 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083845, encodeId=769e108384550, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c82c5636469, createdName=ms2000001848287989, createdTime=Fri Dec 24 10:58:07 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083708, encodeId=e8571083e0835, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/30d83b9eb58247d9a772088edfb77f9e/ca51b8367de94851a2275db463695568.jpg, createdBy=3d162090300, createdName=齐广西, createdTime=Thu Dec 23 22:56:18 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064547, encodeId=52e2106454eb8, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Oct 28 07:01:39 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061364, encodeId=50af106136404, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1e05489924, createdName=ms1000002136354097, createdTime=Mon Oct 18 06:43:36 CST 2021, time=2021-10-18, status=1, ipAttribution=)]
    2021-12-24 ms2000001848287989

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1083850, encodeId=8b0a1083850f4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d9a5236987, createdName=10188348, createdTime=Fri Dec 24 11:04:24 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083845, encodeId=769e108384550, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c82c5636469, createdName=ms2000001848287989, createdTime=Fri Dec 24 10:58:07 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083708, encodeId=e8571083e0835, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/30d83b9eb58247d9a772088edfb77f9e/ca51b8367de94851a2275db463695568.jpg, createdBy=3d162090300, createdName=齐广西, createdTime=Thu Dec 23 22:56:18 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064547, encodeId=52e2106454eb8, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Oct 28 07:01:39 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061364, encodeId=50af106136404, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1e05489924, createdName=ms1000002136354097, createdTime=Mon Oct 18 06:43:36 CST 2021, time=2021-10-18, status=1, ipAttribution=)]
    2021-12-23 齐广西

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1083850, encodeId=8b0a1083850f4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d9a5236987, createdName=10188348, createdTime=Fri Dec 24 11:04:24 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083845, encodeId=769e108384550, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c82c5636469, createdName=ms2000001848287989, createdTime=Fri Dec 24 10:58:07 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083708, encodeId=e8571083e0835, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/30d83b9eb58247d9a772088edfb77f9e/ca51b8367de94851a2275db463695568.jpg, createdBy=3d162090300, createdName=齐广西, createdTime=Thu Dec 23 22:56:18 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064547, encodeId=52e2106454eb8, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Oct 28 07:01:39 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061364, encodeId=50af106136404, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1e05489924, createdName=ms1000002136354097, createdTime=Mon Oct 18 06:43:36 CST 2021, time=2021-10-18, status=1, ipAttribution=)]
    2021-10-28 微探

    学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1083850, encodeId=8b0a1083850f4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d9a5236987, createdName=10188348, createdTime=Fri Dec 24 11:04:24 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083845, encodeId=769e108384550, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c82c5636469, createdName=ms2000001848287989, createdTime=Fri Dec 24 10:58:07 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083708, encodeId=e8571083e0835, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/30d83b9eb58247d9a772088edfb77f9e/ca51b8367de94851a2275db463695568.jpg, createdBy=3d162090300, createdName=齐广西, createdTime=Thu Dec 23 22:56:18 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064547, encodeId=52e2106454eb8, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Oct 28 07:01:39 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061364, encodeId=50af106136404, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1e05489924, createdName=ms1000002136354097, createdTime=Mon Oct 18 06:43:36 CST 2021, time=2021-10-18, status=1, ipAttribution=)]
    2021-10-18 ms1000002136354097

    学习

    0

拓展阅读

骨髓增生异常综合征-难治性贫血伴原始 细胞过多（MDS-RAEB）临床路径

中华人民共和国国家卫生和计划生育委员会(NHFPC,National Health and Family Planning Commission of China) · 2016-04-21

儿童骨髓增生异常综合征诊断与治疗中国专家共识(2015年版)

中华医学会儿科学分会血液学组 · 2016-04-27

骨髓增生异常综合征中西医结合诊疗专家共识（2018年）

中国中西医结合学会(CAIM,Chinese Association of Integrative Medicine) · 2018-07-20

2018 加拿大MDS联盟循证指南：骨髓增生异常综合征铁过载

国外血液科相关专家小组 · 2018-09-19

2018 专家共识建议：接受积极治疗的骨髓增生异常综合征患者感染控制

国外血液科相关专家小组 · 2018-10-28

骨髓增生异常综合征中国诊断与治疗指南（2019年）

中华医学会血液学分会(CMA,CHINESE MEDICAL ASSOCIATION) · 2019-02-20